These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21909131)

  • 21. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer.
    Ying H; Willingham MC; Cheng SY
    Oncogene; 2008 Jan; 27(6):823-30. PubMed ID: 17653082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation suppression prevents tumor cell proliferation in a mouse model of thyroid cancer.
    Park S; Kim M; Zhu J; Lee WK; Altan-Bonnet G; Meltzer P; Cheng SY
    Am J Cancer Res; 2020; 10(6):1857-1870. PubMed ID: 32642296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor.
    Guigon CJ; Zhao L; Lu C; Willingham MC; Cheng SY
    Mol Cell Biol; 2008 Jul; 28(14):4598-608. PubMed ID: 18474620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary homeobox 2 (PITX2) promotes thyroid carcinogenesis by activation of cyclin D2.
    Huang Y; Guigon CJ; Fan J; Cheng SY; Zhu GZ
    Cell Cycle; 2010 Apr; 9(7):1333-41. PubMed ID: 20372070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model.
    Park S; Zhu J; Altan-Bonnet G; Cheng SY
    Am J Cancer Res; 2019; 9(7):1439-1453. PubMed ID: 31392080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice.
    Zimonjic DB; Kato Y; Ying H; Popescu NC; Cheng SY
    Cancer Genet Cytogenet; 2005 Sep; 161(2):104-9. PubMed ID: 16102579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma.
    Ying H; Suzuki H; Furumoto H; Walker R; Meltzer P; Willingham MC; Cheng SY
    Carcinogenesis; 2003 Sep; 24(9):1467-79. PubMed ID: 12869418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model.
    Kim DW; Walker RL; Meltzer PS; Cheng SY
    Carcinogenesis; 2013 Oct; 34(10):2389-400. PubMed ID: 23698635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of integrin-ERBB2 signaling in undifferentiated thyroid cancer.
    Zhu X; Zhu YJ; Kim DW; Meltzer P; Cheng SY
    Am J Cancer Res; 2014; 4(6):776-88. PubMed ID: 25520867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling.
    O'Shea PJ; Kim DW; Logan JG; Davis S; Walker RL; Meltzer PS; Cheng SY; Williams GR
    J Biol Chem; 2012 May; 287(21):17812-17822. PubMed ID: 22442145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid hormone receptor beta mutations in the 'hot-spot region' are rare events in thyroid carcinomas.
    Rocha AS; Marques R; Bento I; Soares R; Magalhães J; de Castro IV; Soares P
    J Endocrinol; 2007 Jan; 192(1):83-6. PubMed ID: 17210745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer.
    Kim CS; Furuya F; Ying H; Kato Y; Hanover JA; Cheng SY
    Endocrinology; 2007 Mar; 148(3):1306-12. PubMed ID: 17170101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma.
    Kim CS; Vasko VV; Kato Y; Kruhlak M; Saji M; Cheng SY; Ringel MD
    Endocrinology; 2005 Oct; 146(10):4456-63. PubMed ID: 16002527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1).
    Fozzatti L; Lu C; Kim DW; Park JW; Astapova I; Gavrilova O; Willingham MC; Hollenberg AN; Cheng SY
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17462-7. PubMed ID: 21987803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knock-in mouse model for resistance to thyroid hormone (RTH): an RTH mutation in the thyroid hormone receptor beta gene disrupts cochlear morphogenesis.
    Griffith AJ; Szymko YM; Kaneshige M; Quiñónez RE; Kaneshige K; Heintz KA; Mastroianni MA; Kelley MW; Cheng SY
    J Assoc Res Otolaryngol; 2002 Sep; 3(3):279-88. PubMed ID: 12382103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of phenobarbital, pregnenolone-16alpha-carbonitrile, and propylthiouracil on thyroid follicular cell proliferation.
    Hood A; Liu J; Klaassen CD
    Toxicol Sci; 1999 Jul; 50(1):45-53. PubMed ID: 10445752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors.
    Furuya F; Lu C; Guigon CJ; Cheng SY
    Steroids; 2009 Jul; 74(7):628-34. PubMed ID: 19014961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.
    Park JW; Zhao L; Willingham MC; Cheng SY
    Am J Cancer Res; 2017; 7(3):727-739. PubMed ID: 28401024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
    Park JW; Zhao L; Willingham MC; Cheng SY
    Mol Carcinog; 2017 Feb; 56(2):489-498. PubMed ID: 27254276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis.
    Guigon CJ; Cheng SY
    Mol Cell Endocrinol; 2009 Sep; 308(1-2):63-9. PubMed ID: 19549593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.